Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000930413-04-003065
Filing Date
2004-06-29
Accepted
2004-06-29 17:06:46
Documents
9
Period of Report
2004-03-31

Document Format Files

Seq Description Document Type Size
1 c32755_10k.txt 10-K 276076
2 c32755_ex4-2.txt EX-4.2 8216
3 c32755_ex4-3.txt EX-4.3 3509
4 c32755_ex10-10.txt EX-10.10 5610
5 c32755_ex21.txt EX-21 200
6 c32755_ex31-1.txt EX-31.1 3126
7 c32755_ex31-2.txt EX-31.2 3163
8 c32755_ex32-1.txt EX-32.1 1538
9 c32755_ex32-2.txt EX-32.2 1556
  Complete submission text file 0000930413-04-003065.txt   305168
Mailing Address 165 LUDLOW AVENUE NORTHVALE NJ 07647
Business Address 165 LUDLOW AVENUE NORTHVALE NJ 07647 2017502646
ELITE PHARMACEUTICALS INC /DE/ (Filer) CIK: 0001053369 (see all company filings)

EIN.: 223542636 | State of Incorp.: DE | Fiscal Year End: 0331
Type: 10-K | Act: 34 | File No.: 001-15697 | Film No.: 04889191
SIC: 2834 Pharmaceutical Preparations